In an in vivo study on cancer vaccination using mouse tumor models, the impact of therapeutic vaccines was greatly potentiated by disruption of the NKG2A/Qa-1b (conserved ortholog of HLA-E) axis even in a PD-1-refractory mouse model. This evidence concerns the gene PDCD1 and cancer.